Clinical Trial Update: Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Mechanically Ventilated ICU Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing remimazolam besylate to propofol for sedation in mechanically ventilated ICU patients completed, reporting efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• PROPOFOL (Propofol)
• Remimazolam besylate (remimazolam besylate)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Critical Illness | Phase 2 | Status: COMPLETED